Change in CAC between baseline and follow-up | |||||
---|---|---|---|---|---|
Treatment group | Decrease of >30 points | Decrease of 1–30 points | No change | Increase of 1–30 points | Increase of >30 points |
Atorvastatin | 3 (3%) | 18 (19%) | 49 (51%) | 14 (15%) | 12 (13%) |
Placebo | 0 (0%) | 14 (15%) | 49 (54%) | 12 (13%) | 16 (18%) |